Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648207/
http://dx.doi.org/10.1007/s40278-020-85609-7
_version_ 1783607067700887552
collection PubMed
description
format Online
Article
Text
id pubmed-7648207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-76482072020-11-09 Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report Reactions Weekly Case Report Springer International Publishing 2020-11-07 2020 /pmc/articles/PMC7648207/ http://dx.doi.org/10.1007/s40278-020-85609-7 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
title Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
title_full Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
title_fullStr Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
title_full_unstemmed Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
title_short Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
title_sort adalimumab/anakinra/dexamethasone: covid-19 infection, cytomegalovirus reactivation and off-label use: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648207/
http://dx.doi.org/10.1007/s40278-020-85609-7

Ejemplares similares